Fast path: latest quarter results by ticker or company name

Home / ACST.V / Company Profile

Acasti Pharma Inc

ACST.V | Healthcare | TSXV
Website Reports Financials
$0.58
+0.01 (+1.75%)

Key Metrics

Market Cap
$25.88M
P/E Ratio
-1.07
EPS
$-0.54
Beta
N/A
Dividend Yield
N/A
ROE
-67.58%
Current Ratio
4.13

Company Information

Industry
Biotechnology

About Acasti Pharma Inc

Acasti Pharma Inc a biopharmaceutical company engages in the development and commercialization of pharmaceutical products for cardiovascular diseases It is evaluating strategic partnerships for the clinical development of CaPre The company was incorporated in 2002 and is headquartered in Laval Canada

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2023-02-14 $-0.09 $-0.14 +-35.7%
2022-02-14 $-0.11 $-0.08 37.5%
2021-02-09 $-0.59 $-0.41 43.2%
2020-11-16 $-0.10 $-0.64 +-84.4%

Financial Ratios (TTM)

Gross Margin
-371.72%
Operating Margin
-513.40%
Net Margin
-455.58%
ROA
-38.08%
Price to Book
0.26
Price to Sales
1.28